LIGUEROS-SAYLAN, Monica,MATCHABA, Patrice,THUREN, Tom,RIDKER, Paul,LIBBY, Peter,OTTEWELL, Penelope,LAU, Yang Yi,DUGAN, Margaret
申请号：
SG11201911283U
公开号：
SG11201911283UA
申请日:
2018.06.22
申请国别(地区):
SG
年份:
2020
代理人:
摘要：
Use of an IL-1β binding antibody or a functional fragment thereof, especially canakinumab or a functional fragment thereof, or gevokizumab or a functional fragment thereof, and biomarkers for the treatment and/or prevention of cancer with at least partial inflammatory basis.
